On the Trail of BRCA1

Courtesy of Mary-Claire KingAfter 16 years of exhausting research, data collection and computation, Mary-Claire King's lab determined in 1990 that a mutation on chromosome 17 was a common occurrence among women in families that had clusters of breast cancer. This family tree shows one of the families in the study. Squares are men, circles are women. Blackened circles indicate women with breast cancer. A cross through the symbol means that person died.When the paper was published in 1990,1 King b

Written bySam Jaffe
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of Mary-Claire King

After 16 years of exhausting research, data collection and computation, Mary-Claire King's lab determined in 1990 that a mutation on chromosome 17 was a common occurrence among women in families that had clusters of breast cancer. This family tree shows one of the families in the study. Squares are men, circles are women. Blackened circles indicate women with breast cancer. A cross through the symbol means that person died.

When the paper was published in 1990,1 King became an instant celebrity in the world of breast cancer research. But it took hundreds of charts like these, each accounting for massive amounts of shoe leather and creative thought. Says King: "If there's one thing that they don't teach enough about in graduate school, it's that science is so extremely hard."

- Sam Jaffe

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies